NCT01987609View on ClinicalTrials.gov

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

February 28, 2018

Conditions
Psoriasis
Interventions
DRUG

Hylenex

DRUG

Normal Saline

Trial Locations (1)

92122

UCSD Division of Dermatology, San Diego

All Listed Sponsors
lead

Tissa Hata, MD

OTHER

NCT01987609 - Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques | Biotech Hunter | Biotech Hunter